logo

For the Inventor, By the Inventor

London, United Kingdom

Immodulon Therapeutics Limited


USPTO Granted Patents = 12



Trademarks = 2

Forward Citations = 40

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Charles Akle (11 out of 11 patents)

silverMedal John Grange (10 out of 10 patents)

bronzeMedal Kevin Bilyard (6 out of 6 patents)

4.  Satvinder Mudan (3 out of 3 patents)

5.  Laura Rosa Brunet (2 out of 2 patents)

6.  Christopher A Lowry (1 out of 4 patents)

7.  Thorsten Hagemann (1 patent)

8.  Oscar Adelmo Bottasso (6 patents)

9.  John Lawson Stanford (16 patents)

10.  Cynthia Ann Stanford (6 patents)

11.  Graham Mcintyre (0 patent)


12 patents:

1. 12042532 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2024-07-23),
2. 11554166 - Immunogenic treatment of cancer (2023-01-17),
3. 11318193 - Immunogenic treatment of cancer (2022-05-03),
4. 11207405 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2021-12-28),
5. 11000584 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2021-05-11),
6. 10994002 - Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy (2021-05-04),
7. 10925952 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2021-02-23),
8. 10736864 - Immunotherapeutic agent (2020-08-11),
9. 10610578 - Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy (2020-04-07),
10. 10610577 - Checkpoint inhibitor and a whole cellfor use in cancer therapy (2020-04-07),
11. 10071124 - [object Object] (2018-09-11),
12. 8617520 - Cancer therapy (2013-12-31),
Company Overview
Immodulon Therapeutics Limited is a biopharmaceutical company based in London, specializing in the development of innovative immunotherapy treatments. The organization focuses on harnessing the body's immune system to combat various diseases, particularly cancer. By leveraging advanced research in immunology and therapeutic modalities, Immodulon aims to create effective solutions that enhance patient outcomes. The company is committed to advancing its proprietary technologies to address unmet medical needs in the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#283 in London

#1,458 in United Kingdom

#48,163 in the World

London, GB
London, United Kingdom

Immodulon Therapeutics Limited

Forward Citations = 40

6 inventors:

goldMedal Charles Akle (11 out of 11 patents)

silverMedal John Grange (10 out of 10 patents)

bronzeMedal Kevin Bilyard (6 out of 6 patents)

4.  Satvinder Mudan (3 out of 3 patents)

5.  Laura Rosa Brunet (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immodulon Therapeutics Limited. Retrieved from https://idiyas.com/company/immodulon-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…